Indian Air Force Zidovudine Lamivudine Nevirapine Tablets Tender 2026 India - Q2 Drug Procurement & ISI/CDSCO Shelf Life Standards
Bid Publish Date
12-Oct-2026, 11:34 am
Bid End Date
19-Oct-2026, 9:00 am
Progress
Tender Overview
The opportunity is with the Indian Air Force (Department of Military Affairs) for the procurement of Zidovudine + Lamivudine + Nevirapine Tablets (V2) under the Q2 category. While exact quantities and estimated value are not disclosed, the vendor must adhere to data-sheet verification, OEM authorization, and GST compliance. The contract includes an option clause allowing up to 50% quantity variation at the awarded rates, with delivery timelines linked to original and extended periods. Key differentiators include mandatory Data Sheet cross-check and supplier accountability for GST invoicing to the consignee. This tender requires strict pharmacovigilance and non-toxicity assurances for supplied pharmaceuticals.
Technical Specifications & Requirements
- Product name: Zidovudine + Lamivudine + Nevirapine tablets (V2) (Q2)
- Data Sheet upload with bid; align parameters with product specifications to avoid rejection
- Shelf life: minimum of two years per DCGI and CDSCO; on supply date, at least five-sixth of shelf life must remain
- Toxicity considerations: non-toxic, safe for health; provide MSDS if applicable
- Authorization: Manufacturer Authorization or OEM/Original Service Provider details required for authorized distributors
- GST handling: bidder pays GST; realignment per actuals or lower applicable rates; GST invoice must reflect consignee GSTIN; portal GST payment confirmation screenshot required
- Inspection: nominated inspection by buyer's representative; follow relevant IS/ISO standards where applicable
Terms, Conditions & Eligibility
- EMD: amount not disclosed in provided data; bidders should prepare typical government EMD as per regime
- Documents required: PAN, GSTIN, cancelled cheque, EFT mandate, Data Sheet, OEM authorization
- Data Sheet match: any mismatch may lead to bid rejection
- Option clause: up to 50% quantity variation during contract with proportional delivery time adjustments
- Invoicing: invoice raised in consignee name with consignee GSTIN; GST portal payment proof required
- Shelf-life compliance and safety: products must be non-toxic and meet DCGI/CDSCO shelf-life standards
Key Specifications
-
Product: Zidovudine + Lamivudine + Nevirapine tablets (V2) (Q2)
-
Shelf life: minimum 2 years per DCGI and CDSCO; minimum remaining shelf life 5/6 at supply
-
GST handling: bidder to pay GST; invoice in consignee name with GSTIN; GST portal screenshot required
-
Inspection: Nominated Inspection Agency to be appointed by buyer
-
Option clause: quantity may vary up to 50% during/after award at contracted rates
-
Data Sheet must match offered product parameters to avoid rejection
-
Manufacturer Authorization required for authorized distributors
Terms & Conditions
-
EMD amount not disclosed; bidders must anticipate standard EMD as per policy
-
Up to 50% quantity variation with proportional delivery time adjustments
-
GST invoicing must reflect consignee GSTIN and include GST payment proof
Important Clauses
Payment Terms
GST payable by bidder; invoice issued to consignee with GSTIN; GST payment proof via portal
Delivery Schedule
Delivery period linked to original order; additional time calculated by (increased quantity/original quantity) × original period, minimum 30 days
Penalties/Liquidated Damages
Not explicitly stated in available data; standard procurement penalties may apply per policy
Bidder Eligibility
-
Provide PAN and GSTIN documents with bid
-
Demonstrate OEM authorization or manufacturer authorization
-
Adhere to shelf-life and non-toxicity requirements per DCGI/CDSCO
Tender Data
Bid Details
Quantity
1800
Bid Type
Single Packet Bid
Bid Validity
180 (Days)
Bid Type
Service
Evaluation
Total value wise evaluation
Inspection Required
No
Tech Clarification Time
2 Days
Preference & Exemptions
EMD Required
No
MII Purchase Preference
Yes
MII Preference Band
L1+20%
MSE Purchase Preference
Yes
MSE Preference Band
L1+15%
MSE Exemption/Relaxation
Yes
Startup Exemption/Relaxation
Yes
Bid Splitting Applied
No
Requirements
Past Performance
80 %
Experience Required
3 Year (s)
Arbitration Clause
No
Mediation Clause
No
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
Zidovudine + Lamivudine + Nevirapine Tablets (V2) (Q2)
Delivery Details
Max Delivery Days
45
Delivery Locations
1
Delivery Cities
KANPUR CITY
Delivery Locations
| Consignee | Address | City | State | Pincode | Quantity | Delivery Days | Additional Requirement |
|---|---|---|---|---|---|---|---|
| - | KANPUR CITY | KANPUR CITY | - | - | 1800 | 45 | - |
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 3
GeM-Bidding-9965780.pdf
Main Document
Other Documents
OTHER
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Categories
3
🤖 AI-Powered Bidder Prediction
Discover companies most likely to bid on this tender
Required Documents
PAN Card copy
GSTIN copy
Cancelled Cheque copy
EFT Mandate certified by Bank
Data Sheet of offered product
Manufacturer Authorization / OEM authorization certificate
GST invoice and GST payment confirmation screenshot on GeM portal
Frequently Asked Questions
How to bid for Zidovudine Lamivudine Nevirapine tablets tender in India
Bidders must submit PAN, GSTIN, cancelled cheque, EFT mandate, and Data Sheet; include OEM authorization; ensure Data Sheet matches product specs; follow GeM upload for GST invoice and payment confirmation; observe the 50% option clause and delivery timelines linked to the original order.
What documents are required for the IAF drug tender submission in 2026
Required docs include PAN Card, GSTIN, cancelled cheque, EFT mandate, Data Sheet, and Manufacturer/OEM authorization; ensure the GST invoice reflects consignee GSTIN and attach GST portal payment screenshot; submit Data Sheet aligned with product parameters to avoid rejection.
What are the shelf life requirements for the Zidovudine combination tablets
Shelf life must be at least two years per DCGI and CDSCO; at supply, minimum five-sixth of shelf life should remain; non-toxic safety data should accompany the shipment; MSDS may be provided if applicable.
What is the 50% option clause in this IAF procurement
Contract allows up to 50% variation in ordered quantity at contracted rates; delivery time adjusts based on the formula (increase ÷ original) × original delivery period with a minimum of 30 days, extending to the original delivery window.
How is GST handled for the GeM invoicing in this tender
GST is payable by the bidder; invoice must be raised in the consignee's name with their GSTIN; provide GST payment confirmation screenshot on the GeM portal for compliance and timely reimbursement.
What are the inspection requirements for drug procurement by IAF
A nominated inspection agency will inspect on behalf of the buyer; ensure product compliance with Data Sheet and safety standards; provide required MSDS and quality certificates if requested by the inspecting agency.
What are the OEM authorization requirements for authorized distributors
Submit a Manufacturer Authorization certificate detailing OEM name, address, email, and phone; this proves authorized distribution rights for Zidovudine + Lamivudine + Nevirapine tablets; ensure mandatory compliance with product data sheet.